Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,846 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04951817 | 68Ga-PSMA PET/CT for Ra223 Assessment | unknown | N/A | 52 | Chang Gung Memorial HospitalOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT07092007 | NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT06473766 |
| Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses(RFDATA) |
| unknown |
| N/A |
| 50 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER |
| 1 |
| Jun 18, 2025 |
| clinicaltrials |
| NCT00567580 | Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer | unknown | Phase 3 | 1,792 | Radiation Therapy Oncology GroupNETWORK | 4 | May 9, 2025 | clinicaltrials |
| NCT06452004 | Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)(AI-DSS) | unknown | N/A | 600 | University Medical Center GroningenOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study(INSPIRE) | unknown | — | 5,350 | Singlera Genomics Inc.INDUSTRY | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05337189 | A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China | unknown | — | 482 | Creative Biosciences (Guangzhou) Co., Ltd.INDUSTRY | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06566716 | A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass | unknown | — | 1,000 | Cleo Diagnostics LtdINDUSTRY | 1 | Feb 4, 2025 | clinicaltrials |
| NCT06353061 | Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer | unknown | Phase 2 | 51 | Peking Union Medical College HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06237257 | A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer | unknown | Phase 2 | 56 | Shanghai Shengdi Pharmaceutical Co., LtdINDUSTRY | 1 | Dec 24, 2024 | clinicaltrials |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06741150 | NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06250244 | 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 12 | Peking Union Medical College HospitalOTHER | 1 | Dec 11, 2024 | clinicaltrials |
| NCT03108196 | Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder | unknown | N/A | 96 | Zhujiang HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06541314 | Fluzoparib Neoadjuvant Therapy for Ovarian Cancer | unknown | Phase 2 | 48 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT06163963 | Sentinel Lymph Node in Early-Stage Endometrium Cancer | unknown | N/A | 100 | Istanbul UniversityOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06525870 | Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial(Trichlosil) | unknown | Phase 2 | 44 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Nov 14, 2024 | clinicaltrials |
| NCT06677775 | Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy | unknown | — | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Nov 7, 2024 | clinicaltrials |
| NCT06339684 | HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis(HPVImmuno) | unknown | — | 120 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT02558946 | Physical Therapy for Men Undergoing Prostatectomy | unknown | N/A | 113 | Indiana UniversityOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06624813 | Partial Prostatectomy for Prostate Cancer(P-RALP) | unknown | N/A | 50 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | unknown | Phase 1 / Phase 2 | 179 | NGM Biopharmaceuticals, IncINDUSTRY | 3 | Oct 2, 2024 | clinicaltrials |
| NCT05793333 | Predictors of Node Positivity in Endometrial Cancer | unknown | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598085 | Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecological Surgery | unknown | N/A | 20 | Cornerstone RoboticsINDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05116579 | Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi) | unknown | — | 30 | Sun Yat-sen UniversityOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT05099978 | Asian Multicenter Prospective Study of ctDNA Sequencing(A-TRAIN) | unknown | — | 506 | National Cancer Center, JapanOTHER_GOV | 8 | Sep 4, 2024 | clinicaltrials |
| NCT06574763 | Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer | unknown | Phase 2 | 47 | Sun Yat-sen UniversityOTHER | 0 | Aug 28, 2024 | clinicaltrials |
| NCT04575402 | Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients(DigiPRO) | unknown | — | 40 | Cedars-Sinai Medical CenterOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT05475184 | A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor | unknown | Phase 2 | 58 | Onconic Therapeutics Inc.INDUSTRY | 1 | Aug 27, 2024 | clinicaltrials |
| NCT05720832 | Feasibility of Technology-Based SSIP in Prostate Cancer Patients | unknown | N/A | 27 | Wings Health AGINDUSTRY | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06573736 | Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered Validation(S3M-MRI) | unknown | — | 500 | Karolinska InstitutetOTHER | 0 | Aug 27, 2024 | clinicaltrials |
| NCT06565585 | Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma | unknown | — | 800 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06565598 | Single-layer Robot-assisted Transperitoneal Retroperitoneal Tubeless Radical Nephrectomy | unknown | N/A | 150 | The First People's Hospital of XiushuiOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06565923 | Study on the Staging and Prognosis Model of Bladder Cancer(2024-SR-386) | unknown | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT05024162 | Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour(MRI-PREDICT) | unknown | N/A | 60 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05229614 | Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease(ICONIC) | unknown | Phase 2 | 27 | CNAO National Center of Oncological HadrontherapyOTHER | 2 | Aug 21, 2024 | clinicaltrials |
| NCT06564363 | The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma | unknown | — | 148 | Wuhan Ammunition Life-tech Co., LtdINDUSTRY | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06215976 | The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer | unknown | Phase 4 | 78 | Cairo UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT04560725 | PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer | unknown | N/A | 50 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04271527 | Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy | unknown | N/A | 626 | Shanghai East HospitalOTHER | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05867303 | A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors | unknown | Phase 1 | 48 | RemeGen Co., Ltd.INDUSTRY | 2 | Aug 16, 2024 | clinicaltrials |
| NCT01890590 | A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma | unknown | N/A | 46 | Beth Israel Deaconess Medical CenterOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06491888 | A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening | unknown | N/A | 4,200 | Lei LiOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06054867 | PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System | unknown | N/A | 22 | PROCEPT BioRoboticsINDUSTRY | 1 | Aug 14, 2024 | clinicaltrials |
| NCT05684731 | Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer(K19017-004) | unknown | Phase 1 | 30 | Tongji HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550583 | Screening for Early Cervical Cancer Detection | unknown | — | 200 | Assiut UniversityOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550947 | ALDOA Expression in Bladder Urothelial Carcinoma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06551233 | Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) | unknown | Phase 1 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06548867 | Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib(CABOGEN) | unknown | — | 80 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05025878 | 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.(iMETABO) | unknown | — | 10 | British Columbia Cancer AgencyOTHER | 1 | Aug 9, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Aug 29, 2025source: clinicaltrials